Efficacy and safety of switching from basal insulin to once-daily insulin degludec/insulin aspart in Japanese patients with inadequately controlled type 2 diabetes: A 4-week, randomized, open-label, treat-to-target study-Reference-Cited by-同舟云学术

Efficacy and safety of switching from basal insulin to once-daily insulin degludec/insulin aspart in Japanese patients with inadequately controlled type 2 diabetes: A 4-week, randomized, open-label, treat-to-target study

Published:2017-10-29 Issue:3 Volume:9 Page:567-572
ISSN:2040-1116
Container-title:Journal of Diabetes Investigation
language:en
Short-container-title:J Diabetes Investig

Author:

Nagai Yoshio¹^ORCID,Nishine Ami¹,Hashimoto Eriko¹,Nakayama Taiga¹,Sasaki Yosuke¹,Murakami Mariko¹,Ishii Satoshi¹,Kato Hiroyuki¹,Tanaka Yasushi¹

Affiliation:

1. Division of Metabolism and Endocrinology; Department of Internal Medicine; St. Marianna University School of Medicine; Kawasaki Japan

Publisher

Wiley

Subject

General Medicine,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/jdi.12748/fullpdf

Reference18 articles.

1. Comparison of bedtime insulin regimens in patients with type 2 diabetes mellitus. A randomized, controlled trial;Yki-Järvinen;Ann Intern Med,1999

2. Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes;Nathan;Diabetes Care,2009

3. Safety and efficacy of insulin glargine (HOE 901) versus NPH insulin in combination with oral treatment in Type 2 diabetic patients;HOE 901/2004 Study Investigators Group;Diabet Med,2003

4. A one-year, randomised, multicentre trial comparing insulin glargine with NPH insulin in combination with oral agents in patients with type 2 diabetes;Massi Benedetti;Horm Metab Res,2003

5. Less nocturnal hypoglycemia and better post-dinner glucose control with bedtime insulin glargine compared with bedtime NPH insulin during insulin combination therapy in type 2 diabetes;Yki-Järvinen;Diabetes Care,2000

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and Safety of Insulin Degludec/Insulin Aspart Compared with a Conventional Premixed Insulin or Basal Insulin: A Meta-Analysis;Metabolites;2021-09-18

2. Factors that Affect the Glycemic Control Achieved by Switching to Insulin Degludec/ Aspart in Insulin-Treated Patients with Type 1 and Type 2 Diabetes in a Real-World Setting: a Non-Interventional, Retrospective Cohort Study;Acta Endocrinologica (Bucharest);2020

3. Switching to Once-Daily Insulin Degludec/Insulin Aspart from Basal Insulin Improves Postprandial Glycemia in Patients with Type 2 Diabetes Mellitus: Randomized Controlled Trial;Diabetes & Metabolism Journal;2020

4. Comparison of the efficacy and safety of once-daily insulin degludec/insulin aspart (IDegAsp) and long-acting second-generation basal insulin (insulin degludec and insulin glargine 300 units/mL) in insulin-naïve Japanese adults with type 2 diabetes: a pilot, randomized, controlled study;Endocrine Journal;2019